Aura Biosciences, Inc.
AURA
$6.04
-$0.06-0.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.40% | -13.76% | -17.48% | -18.26% | -24.06% |
| Total Depreciation and Amortization | -5.11% | -5.56% | -2.94% | 2.63% | 1.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.99% | 25.03% | 25.50% | 31.50% | 13.90% |
| Change in Net Operating Assets | 348.05% | -159.49% | 120.71% | -361.21% | -1,595.41% |
| Cash from Operations | -9.49% | -24.99% | -13.60% | -22.63% | -28.80% |
| Capital Expenditure | -96.51% | -76.73% | -69.47% | -41.08% | -13.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 344.84% | 161.87% | -24.40% | 12.47% | 65.94% |
| Cash from Investing | 336.78% | 160.39% | -25.23% | 11.59% | 65.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.52% | -98.36% | -5.49% | -3.10% | 1.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.52% | -98.36% | -5.49% | -3.10% | 1.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 197.66% | 88.34% | -430.89% | -182.83% | 82.34% |